Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Autophagy ; 4(1): 88-90, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17957135

ABSTRACT

Autophagy is a homeostatic process for recycling of proteins and organelles, that increases during times of nutrient deprivation and is regulated by reactive oxygen species. We reported that autophagy can also be induced after traumatic brain injury (TBI) in mice.1 Specifically, autophagosomes and multilamellar bodies were frequently observed in cell processes and axons in injured brain regions by electron microscopy, and lipidated microtubule-associated protein light chain 3 (LC3-II), was increased after TBI vs. controls. To determine if antioxidants could reduce autophagy, separate mice were treated with the antioxidant ?-glutamylcysteinyl ethyl ester (GCEE). Treatment with GCEE preserved total antioxidant reserves, reduced LC3-II in injured brains, and improved both behavioral and histological outcome after TBI. Here we report that LC3-II and autophagosomes were detectable in brain tissue from humans after TBI. Taken together, we show that autophagy occurs after both experimental and clinical TBI, and that oxidative stress contributes to overall neuropathology after TBI in mice, at least in part by initiating or influencing autophagy.


Subject(s)
Autophagy/physiology , Brain Injuries , Brain/pathology , Critical Illness , Animals , Antioxidants/metabolism , Apoptosis Regulatory Proteins/metabolism , Beclin-1 , Brain Injuries/pathology , Brain Injuries/physiopathology , Dipeptides/metabolism , Humans , Membrane Proteins/metabolism , Mice , Microtubule-Associated Proteins/metabolism , Neurons/cytology , Neurons/metabolism , Oxidative Stress
2.
J Cereb Blood Flow Metab ; 27(2): 316-26, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16736044

ABSTRACT

The pathobiology of traumatic brain injury (TBI) includes activation of multiple caspases followed by cell death with a spectrum of apoptotic phenotypes. There are initiator (e.g. caspase-2, -8, and -9) and effector (e.g. caspase-3 and -7) caspases. Recently, caspase-2 and -8 have been shown to regulate cell death via provoking cytochrome c release from the mitochondria upstream of caspase-9. Here, we show that an intracerebral injection of the pan-caspase inhibitor boc-Aspartyl(OMe)-fluoromethylketone (BAF; 1 micromol) 1 min after TBI in rats reduces caspase-3-like activity, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and tissue damage, and cytochrome c release in ipsilateral cortex at 24 h versus vehicle. To investigate whether either caspase-2 and/or caspase-8 activation may contribute to cytochrome release, the effect of BAF treatment on caspase-2 and caspase-8 proteolysis was also examined. boc-aspartyl(OMe)-fluoromethylketone treatment inhibited proteolysis of caspase-2 but not caspase-8 24 h after TBI in rats versus vehicle. However, BAF with or without nerve growth factor (12.5 ng/h x 14 days intracerebrally via osmotic pump) did not result in differences in motor function, Morris water maze performance, hippocampal neuron survival, nor contusion volume at 14 days. These data suggest that BAF treatment reduces acute cell death after TBI by inhibiting mitochondrial release of cytochrome c, possibly via a mechanism involving initiator caspases; however, BAF appears to delay cell death, rather than result in permanent protection.


Subject(s)
Amino Acid Chloromethyl Ketones/pharmacology , Brain Injuries/drug therapy , Brain Injuries/pathology , Brain/pathology , Cytochromes c/metabolism , Mitochondria/enzymology , Neuroprotective Agents , Animals , Blotting, Western , Brain/enzymology , Brain Injuries/enzymology , Caspase 2/metabolism , Caspase 3/metabolism , Caspase 8/metabolism , Cell Survival/drug effects , In Situ Nick-End Labeling , Male , Maze Learning/physiology , Mitochondria/drug effects , Nerve Growth Factor/metabolism , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/isolation & purification , Rats , Rats, Sprague-Dawley
3.
Cancer Res ; 66(9): 4895-903, 2006 May 01.
Article in English | MEDLINE | ID: mdl-16651446

ABSTRACT

Dendritic cells play significant roles in the development and maintenance of antitumor immune responses. Therapeutic recruitment of dendritic cells into the tumor microenvironment has the potential to result in enhanced antitumor T-cell cross-priming against a broad array of naturally processed and presented tumor-associated antigens. We have observed that the treatment of BALB/c mice bearing syngeneic CMS4 sarcomas with the combination of recombinant Flt3 ligand and recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) for five sequential days is sufficient to optimize the number of tumor-infiltrating dendritic cells (TIDC). However, despite the significant increase in the number of TIDCs, the therapeutic benefit of Flt3 ligand and GM-CSF treatment is minimal. Therapy-associated TIDCs do not exhibit a "suppressed" or "suppressor" phenotype in vitro, and their enhanced numbers in cytokine-treated mice were associated with increased levels of peripheral antitumor CD8(+) T effector cells and with an augmented population of CD8(+) tumor-infiltrating lymphocytes (TIL). These data suggest that Flt3 ligand + GM-CSF therapy of murine tumors fails at a mechanistic point that is downstream of specific T-cell priming by therapy-induced TIDCs and the recruitment of these T cells into the tumor microenvironment. Based on the enhanced infiltration of tumors by CD4(+)CD25(+) TIL in Flt3 ligand + GM-CSF-treated mice, this could reflect the dominant influence of regulatory T cells in situ.


Subject(s)
CD8-Positive T-Lymphocytes/drug effects , Dendritic Cells/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Immunotherapy/methods , Membrane Proteins/pharmacology , Neoplasms, Experimental/immunology , Neoplasms, Experimental/therapy , Animals , CD8-Positive T-Lymphocytes/immunology , Cell Line, Tumor , Cross Reactions , Cytokines/immunology , Dendritic Cells/immunology , Female , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Lymphocytes, Tumor-Infiltrating/drug effects , Lymphocytes, Tumor-Infiltrating/immunology , Membrane Proteins/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Spleen/drug effects , Spleen/immunology
4.
J Exp Med ; 202(7): 941-53, 2005 Oct 03.
Article in English | MEDLINE | ID: mdl-16203865

ABSTRACT

In addition to their cytotoxic activities, natural killer (NK) cells can have immunoregulatory functions. We describe a distinct "helper" differentiation pathway of human CD56+CD3- NK cells into CD56+/CD83+/CCR7+/CD25+ cells that display high migratory responsiveness to lymph node (LN)-associated chemokines, high ability to produce interferon-gamma upon exposure to dendritic cell (DC)- or T helper (Th) cell-related signals, and pronounced abilities to promote interleukin (IL)-12p70 production in DCs and the development of Th1 responses. This helper pathway of NK cell differentiation, which is not associated with any enhancement of cytolytic activity, is induced by IL-18, but not other NK cell-activating factors. It is blocked by prostaglandin (PG)E2, a factor that induces a similar CD83+/CCR7+/CD25+ LN-homing phenotype in maturing DCs. The current data demonstrate independent regulation of the "helper" versus "effector" pathways of NK cell differentiation and novel mechanisms of immunoregulation by IL-18 and PGE2.


Subject(s)
Antigens, CD/immunology , Cell Differentiation/immunology , Cell Movement/immunology , Immunoglobulins/immunology , Killer Cells, Natural/cytology , Membrane Glycoproteins/immunology , Receptors, Chemokine/immunology , T-Lymphocytes, Helper-Inducer/cytology , Cell Line , Chemotaxis/immunology , Cytokines/immunology , Dendritic Cells/immunology , Dendritic Cells/metabolism , Flow Cytometry , Humans , Interferon-gamma/metabolism , Interleukins/metabolism , Killer Cells, Natural/immunology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Receptors, CCR7 , T-Lymphocytes, Helper-Inducer/immunology , CD83 Antigen
5.
Clin Immunol ; 114(2): 199-209, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15639654

ABSTRACT

We have shown that tacrolimus (TAC)-induced liver allograft acceptance is associated with migration and persistence of donor B cells and dendritic cells (DC). To clarify whether these MHC class II+ leukocytes have favorable roles in inducing tolerance, we analyzed recipient T cell reactions after allogeneic B or DC infusion. LEW rat B cells localized exclusively in BN host B cell follicles without any direct contact with host T cells. While few donor DC migrated to T cell areas and marginal zones, they were captured by host APC, suggesting that allogeneic MHC class II+ cells may induce immune reactions via the indirect pathway. Although DC-infused non-immunosuppressed recipients showed enhanced ex vivo anti-donor responses, persistent in vitro donor-specific hyporeactivity was seen equally with donor DC or B cell infusion under TAC. The results indicate that donor MHC class II+ APC are capable of regulating recipient immune reactions under TAC. Possible involvement of the indirect pathway of allorecognition is discussed.


Subject(s)
B-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/immunology , Dendritic Cells/immunology , Immunosuppressive Agents/pharmacology , Tacrolimus/pharmacology , Animals , CD4-Positive T-Lymphocytes/drug effects , Flow Cytometry , Heart Transplantation/immunology , Histocompatibility Antigens Class II/immunology , Immune Tolerance/drug effects , Immune Tolerance/immunology , Immunohistochemistry , Interferon-gamma , Lymphocyte Culture Test, Mixed , Male , Rats , Rats, Inbred BN , Rats, Inbred Lew , Specific Pathogen-Free Organisms
6.
Cancer Res ; 64(22): 8381-8, 2004 Nov 15.
Article in English | MEDLINE | ID: mdl-15548708

ABSTRACT

The overexpression of the inhibitor of apoptosis protein, survivin, may provide tumor cells with a distinct survival advantage in situ; hence, therapeutic strategies have been designed to inhibit its expression. In this study, we ectopically expressed the interferon regulatory factor (IRF)-1 protein in the breast carcinoma cell lines MDA-MB-468 and SK-BR-3 using a recombinant adenovirus (Ad-IRF-1). By screening microarray analysis of cDNA from the human breast cancer cell line MDA-MB-468 infected with Ad-IRF-1, we observed a 15-fold down-regulation of the survivin gene when compared with uninfected cells. Consequently, we tested survivin expression in Ad-IRF-1-infected MDA-MB-468 and SK-BR-3 breast cancer cell lines. Immunoblotting analyses supported the contention that ectopic expression of the IRF-1 protein results in down-regulation of survivin protein expression that is independent of p53. In addition, Ad-IRF-1 infection of these human breast cancer cell lines induces the expression of p21. We also report that increased apoptosis is observed in tumor cells infected with Ad-IRF-1 compared with Ad-Psi5 mock-infected cells and that cell death is further augmented when the IRF-1-infected cells are cultured with Adriamycin. Moreover, in a xenogeneic mouse model of breast carcinoma, in vivo treatment of tumor-bearing mice with intratumoral Ad-IRF-1 injections results in tumor growth inhibition. In resected tumors from mice that had been treated with Ad-IRF-1, tumor cells that express the IRF-1 transgene have a predominant IRF-1-positive, survivin-negative phenotype. Collectively, these observations suggest that therapies designed to enhance IRF-1 expression within tumor cells may represent novel treatment strategies for breast cancer.


Subject(s)
Apoptosis , Breast Neoplasms/pathology , DNA-Binding Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Phosphoproteins/metabolism , Animals , Breast Neoplasms/metabolism , Cell Line, Tumor , Doxorubicin/pharmacology , Humans , Immunohistochemistry , Inhibitor of Apoptosis Proteins , Interferon Regulatory Factor-1 , Mice , Neoplasm Proteins , Survivin
7.
Proc Natl Acad Sci U S A ; 101(41): 14895-900, 2004 Oct 12.
Article in English | MEDLINE | ID: mdl-15469929

ABSTRACT

To better understand the molecular basis of chronic obstructive pulmonary disease (COPD), we used serial analysis of gene expression (SAGE) and microarray analysis to compare the gene expression patterns of lung tissues from COPD and control smokers. A total of 59,343 tags corresponding to 26,502 transcripts were sequenced in SAGE analyses. A total of 327 genes were differentially expressed (1.5-fold up- or down-regulated). Microarray analysis using the same RNA source detected 261 transcripts that were differentially expressed to a significant degree between GOLD-2 and GOLD-0 smokers. We confirmed the altered expression of a select number of genes by using real-time quantitative RT-PCR. These genes encode for transcription factors (EGR1 and FOS), growth factors or related proteins (CTGF, CYR61, CX3CL1, TGFB1, and PDGFRA), and extracellular matrix protein (COL1A1). Immunofluorescence studies on the same lung specimens localized the expression of Egr-1, CTGF, and Cyr61 to alveolar epithelial cells, airway epithelial cells, and stromal and inflammatory cells of GOLD-2 smokers. Cigarette smoke extract induced Egr-1 protein expression and increased Egr-1 DNA-binding activity in human lung fibroblast cells. Cytomix (tumor necrosis factor alpha, IL-1beta, and IFN-gamma) treatment showed that the activity of matrix metalloproteinase-2 (MMP-2) was increased in lung fibroblasts from EGR1 control (+/+) mice but not detected in that of EGR1 null (-/-) mice, whereas MMP-9 was regulated by EGR1 in a reverse manner. Our study represents the first comprehensive analysis of gene expression on GOLD-2 versus GOLD-0 smokers and reveals previously unreported candidate genes that may serve as potential molecular targets in COPD.


Subject(s)
Gene Expression Profiling , Gene Expression Regulation/physiology , Pulmonary Disease, Chronic Obstructive/genetics , Pulmonary Disease, Chronic Obstructive/physiopathology , Aged , DNA-Binding Proteins/genetics , Early Growth Response Protein 1 , Humans , Immediate-Early Proteins/genetics , Lung/pathology , Middle Aged , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Smoking/pathology , Transcription Factors/genetics
8.
Crit Care Med ; 32(7): 1453-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15241088

ABSTRACT

OBJECTIVE: Ethyl pyruvate has been shown to be an effective anti-inflammatory agent in a variety of in vitro and in vivo model systems. Herein, we used a murine model of acute pancreatitis to compare the effects of treatment with either Ringer's lactate solution or ethyl pyruvate solution on several physiologic and biochemical variables related to disease severity. DESIGN: Experimental animal study. SETTING: University laboratory. SUBJECTS: C57Bl/6 mice. INTERVENTIONS: Pancreatitis was induced by feeding the animals a choline-deficient diet supplemented with 0.5% ethionine for 24 hrs and then challenging the animals with seven hourly 50 microg/kg intraperitoneal injections of cerulein and a single intraperitoneal injection of Escherichia coli lipopolysaccharide (4 mg/kg). MEASUREMENTS AND MAIN RESULTS: When mice were treated with ethyl pyruvate (40 mg/kg intraperitoneally every 6 hrs for 48 hrs) instead of Ringer's lactate solution starting 2 hrs after the injection of lipopolysaccharide, long-term survival was improved from one of ten to six of ten (p =.057). When mice were treated with a 40 mg/kg dose of ethyl pyruvate just before the first dose of cerulein and then injected with a second 40 mg/kg dose 6 hrs later, serum concentrations of alanine aminotransferase measured 10 hrs after the first cerulein dose were significantly lower than in mice with pancreatitis treated with Ringer's lactate solution. In this model of acute pancreatitis, the same dosing regimen for ethyl pyruvate also ameliorated bacterial translocation to mesenteric lymph nodes and leakage of fluorescein isothiocyanate-labeled albumin from blood into bronchoalveolar lavage fluid. Treatment with ethyl pyruvate decreased pancreatic expression of tumor necrosis factor and interleukin-6 messenger RNA and nuclear factor-kappaB DNA binding in nuclear extracts prepared from pancreatic tissue. CONCLUSION: Treatment with ethyl pyruvate ameliorated the local inflammatory response and decreased local and distant organ injury in a murine model of necrotizing pancreatitis.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Pancreatitis, Acute Necrotizing/drug therapy , Pyruvates/therapeutic use , Animals , Isotonic Solutions/therapeutic use , Male , Mice , Mice, Inbred C57BL , Pancreatitis, Acute Necrotizing/complications , Pancreatitis, Acute Necrotizing/pathology , Respiratory Distress Syndrome/complications , Respiratory Distress Syndrome/drug therapy , Reverse Transcriptase Polymerase Chain Reaction , Ringer's Lactate
9.
Br J Haematol ; 124(3): 358-65, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14717785

ABSTRACT

Prolonged quiescence of haematopoietic stem cells has been proposed to support durable haematopoiesis through clonal succession. Genetic experiments in mice have implicated the cyclin-dependent kinase inhibitor (cdki) p21Waf1 in sustaining stem cell quiescence, and the cdki p27Kip1 in inhibiting the expansion of more mature progenitor cells. The expression of these inhibitory proteins in human haematopoietic stem cell candidates has not hitherto been studied. We describe a rare subpopulation (3 x 10-7 umbilical cord mononuclear cells) of lineage-negative cells that exhibited sustained resistance over months to cytokine-induced cycling, and characterized the expression of p21Waf1 and p27Kip1 proteins in these cells. Whereas p27Kip1 was uniformly expressed in these cells, the expression of p21Waf1 in this population and in lineage-negative CD34+ cells was variable. For this rare subset of cells exhibiting prolonged quiescence, p21Waf1 may be dispensable and p27Kip1 necessary for growth arrest.


Subject(s)
Cyclin-Dependent Kinases/antagonists & inhibitors , Cyclins/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , CD4-Positive T-Lymphocytes/cytology , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Cycle Proteins/analysis , Cell Separation/methods , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p27 , Cyclins/analysis , Cytokines/pharmacology , Flow Cytometry , Fluorouracil/pharmacology , Granulocyte Colony-Stimulating Factor/pharmacology , Humans , Immunosuppressive Agents/pharmacology , Interleukin-3/pharmacology , Microscopy, Confocal , Stem Cell Factor/pharmacology , Tumor Suppressor Proteins/analysis
10.
Cancer Res ; 63(19): 6378-86, 2003 Oct 01.
Article in English | MEDLINE | ID: mdl-14559827

ABSTRACT

Dendritic cells (DCs) were adenovirally engineered to constitutively and durably secrete the potent Th1-biasing cytokines interleukin (IL)-12 (AdIL12DC) and/or IL-18 (AdIL18DC) and evaluated for their ability to promote therapeutic antitumor immunity in murine sarcoma models. Injection of either AdIL12DC or AdIL18DC into day 7 CMS4 or MethA tumors resulted in tumor rejection or slowed tumor growth when compared with control cohorts. Importantly, intratumoral injection with DCs engineered to secrete both IL-12 and IL-18 (AdIL12/IL18DC) resulted in complete and the most acute rejection of any treatment group analyzed. This strategy was also effective in promoting the regression of contralateral, untreated tumors. Both CD4+ and CD8+ T cells were required for tumor rejection. CD8+ splenic T cells from mice treated with AdIL12/IL18DC produced the highest levels of IFN-gamma in response to tumor rechallenge in vitro and displayed the broadest repertoire of Tc1-type reactivity to acid-eluted, tumor-derived peptides among all treatment cohorts. This apparent enhancement in cross-presentation of tumor-associated epitopes in vivo may result from the increased capacity of engineered DCs to kill tumor cells, survive tumor-induced apoptosis, and present immunogenic MHC/tumor peptide complexes to T cells after intratumoral injection. In support of this hypothesis, cytokine gene-engineered DCs expressed higher levels of MHC and costimulatory molecules, as well as Fas ligand and membrane-bound tumor necrosis factor alpha, with the latter markers associated with elevated tumoricidal activity in vitro. Cytokine gene-engineered DCs appeared to have a survival advantage in situ when injected into tumor lesions, to be found in approximation with regions of tumor apoptosis, and to have the capacity to ingest apoptotic tumor bodies. These results support the ability of combined cytokine gene transfer to enhance multiple effector functions mediated by intralesionally injected DCs that may concertedly promote cross-priming and the accelerated immune-mediated rejection of tumors.


Subject(s)
Dendritic Cells/immunology , Immunotherapy, Adoptive/methods , Interleukin-12/immunology , Interleukin-18/immunology , Sarcoma, Experimental/therapy , Th1 Cells/immunology , Adenoviridae/genetics , Animals , Apoptosis Regulatory Proteins , CD8-Positive T-Lymphocytes/immunology , Dendritic Cells/metabolism , Dendritic Cells/physiology , Dendritic Cells/virology , Epitopes, T-Lymphocyte/immunology , Female , Interleukin-12/biosynthesis , Interleukin-12/genetics , Interleukin-12/metabolism , Interleukin-18/biosynthesis , Interleukin-18/genetics , Interleukin-18/metabolism , Lymphotoxin-alpha/biosynthesis , Membrane Glycoproteins/biosynthesis , Mice , Mice, Inbred BALB C , Sarcoma, Experimental/immunology , TNF-Related Apoptosis-Inducing Ligand , Th1 Cells/metabolism , Transduction, Genetic , Tumor Necrosis Factor-alpha/biosynthesis
11.
Am J Pathol ; 163(1): 231-42, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12819027

ABSTRACT

Successful lung transplantation has been limited by the high incidence of acute graft rejection. There is mounting evidence that the stress response gene heme oxygenase-1 (HO-1) and/or its catalytic by-product carbon monoxide (CO) confers cytoprotection against tissue and cellular injury. This led us to hypothesize that CO may protect against lung transplant rejection via its anti-inflammatory and antiapoptotic effects. Orthotopic left lung transplantation was performed in Lewis rat recipients from Brown-Norway rat donors. HO-1 mRNA and protein expression were markedly induced in transplanted rat lungs compared to sham-operated control lungs. Transplanted lungs developed severe intraalveolar hemorrhage, marked infiltration of inflammatory cells, and intravascular coagulation. However, in the presence of CO exposure (500 ppm), the gross anatomy and histology of transplanted lungs showed marked preservation. Furthermore, transplanted lungs displayed increased apoptotic cell death compared with the transplanted lungs of CO-exposed recipients, as assessed by TUNEL and caspase-3 immunostaining. CO exposure inhibited the induction of IL-6 mRNA and protein expression in lung and serum, respectively. Gene array analysis revealed that CO also down-regulated other proinflammatory genes, including MIP-1alpha and MIF, and growth factors such as platelet-derived growth factor, which were up-regulated by transplantation. These data suggest that the anti-inflammatory and antiapoptotic properties of CO confer potent cytoprotection in a rat model of lung transplantation.


Subject(s)
Anti-Inflammatory Agents/metabolism , Apoptosis/physiology , Carbon Monoxide/metabolism , Cytoprotection , Graft Rejection , Lung Transplantation , Animals , Caspase 3 , Caspases/metabolism , Cells, Cultured , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Expression Profiling , Heme Oxygenase (Decyclizing)/genetics , Heme Oxygenase (Decyclizing)/metabolism , Heme Oxygenase-1 , Humans , In Situ Nick-End Labeling , Interleukin-6/metabolism , Lung/cytology , Lung/metabolism , Lung/pathology , Male , Membrane Proteins , Oligonucleotide Array Sequence Analysis , Peroxidase/metabolism , Rats
12.
Am J Physiol Renal Physiol ; 284(5): F925-9, 2003 May.
Article in English | MEDLINE | ID: mdl-12540363

ABSTRACT

The existence of a pacemaker system in the urinary tract capable of orchestrating the movement of filtrated urine from the ureteral pelvis to the distal ureter and lower urinary tract seems intuitive. The coordinated activity necessary for such movement or "peristalsis" would likely require an intricate network of cells with pacemaker-like activity, as is the case with the interstitial cells of Cajal (ICC) of the gut. We investigated whether these putative pacemaker cells of the urinary tract are antigenically similar to ICC of the gut by using immunofluorescence staining for c-kit, a cell-surface marker specific for ICC. Ureteral, urinary bladder, and urethral tissues were harvested from female mice of the WBB6F1 strain, and fixed sections were prepared and stained for c-kit. Cell networks composed of stellate-appearing, c-kit-positive, ICC-like cells were found in the lamina propria and at the interface of the inner longitudinal and outer circular muscle layers of the ureteral pelvis but not in the urinary bladder or urethra. Thus, like in the gut, c-kit-positive, ICC-like cells are present in the urinary tract but appear to be restricted to the proximal ureter of this murine species.


Subject(s)
Biological Clocks/physiology , Proto-Oncogene Proteins c-kit/metabolism , Ureter/cytology , Ureter/physiology , Animals , Female , Fluorescent Antibody Technique , Mice , Mice, Inbred Strains , Microscopy, Confocal
SELECTION OF CITATIONS
SEARCH DETAIL
...